DIGIPHARMs’ solutions will facilitate & accelerate the paradigm shift to value-based & patient centric healthcare using ‘smart contracts’ & blockchain technology. Utilising blockchain technology for DIGIPHARMs’ platforms promotes the development of a decentralised health information infrastructure that is ubiquitous, transparent & security conscious.
Reimburse is the world’s first smart contract platform for flexible pricing of healthcare based on treatment performance.
It eliminates infrastructural barriers & automates the implementation of value-based pricing agreements between payer & manufacturer, regardless of complexity, on a fully independent platform.
Removing the administrative burden encourages payment for performance for the mutual benefit for all stakeholders.
DIGIHEALTH provides patients with the ability to access personalised, comprehensive & up-to-date health information to inform their decision making. Patients are rewarded for participating in health-related research and sharing health data.
Insights is a ‘live’ health outcomes database for health-related decision making and research, where health data and real world evidence (RWE) is accessible and updated in real time. Patients are rewarded for contributing data to Insights.
MYHEALTH is an application that will be used in collaboration with payers & providers to track patients’ health related behaviour & reward or incentivise them accordingly.
Data collection on the MYHEALTH platform will allow health insurance providers to identify lower risk patients & offer subsequent reductions in health insurance premiums.
Evolve is a platform for crowdfunding medical innovation. Funds will be raised via tokenization & digital assetization of innovative health technology to support early proof-of-concept research, ex-vivo studies & pre-clinical studies.
This platform will become the new standard for early funding phases in medical innovation & drug development especially for orphan diseases.
benefit from receiving innovative therapy, only paying for treatment that works, and from finally having control of their own data.
benefit from the removal of administrative burdens and an improved collaboration with manufacturers to provide personalised care.
benefit from providing the best available treatments to their citizens, only paying for treatments that work, and the removal of administrative burdens.
benefit from covering patients for the best healthcare, only paying for treatment that works, and being able to trust patient data provided by counterparties with minimal administrative costs.
benefit from an easier route to market and an opportunity to showcase the value of their innovations.